March 16, 2021
Nihon Pharmaceutical said on March 12 that Hidemasa Tanigaki, who leads the Japan rare hematology business at Takeda Pharmaceutical, has been named its president effective April 1, when the company is scheduled to become a wholly owned subsidiary of the...read more